Results for tag: "Lymphopenia Drug"

The Lymphopenia Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions that affect the body's ability to fight off infection. These drugs are used to treat conditions such as HIV/AIDS, rheumatoid arthritis, and lupus. They work by boosting the body's immune system, allowing it to better fight off infection. Lymphopenia drugs are used to treat a specific type of immune disorder, known as lymphopenia, which is characterized by a low level of white blood cells. These drugs work by increasing the number of white blood cells in the body, allowing it to better fight off infection. Some of the major companies in the Lymphopenia Drug market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more